Massimiliano Cerletti

Massimiliano Cerletti

Auto-generated profile, based on publicly available information

Massimiliano Cerletti

Tissue Repair and Regeneration Centre, Division of Surgery & Interventional Science, University College London, Royal Free Campus, London, NW3 2PF, UK; Centre for Surgical Innovation, Organ Repair and Transplantation (CSIORT), University College London, Royal Free Campus, London, NW3 2PF, UK; Centre for Bioengineering and Surgical Technology (BEST), University College London, Brockley Hill, Stanmore, HA7 4AP, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2025 in Biomaterials
Verified
Journal Article
Open access
SZShudong Zhao
Shudong Zhao
LWLei Wu
Lei Wu
STSara Taiyari
Sara Taiyari
HLHuiliang Li
Huiliang Li
JSJianfei Sun
Jianfei Sun
MCMassimiliano Cerletti
Massimiliano Cerletti
Skeletal muscle stem cells, also known as satellite cells, have remarkable self-renewal abilities in response to muscle injury, playing a vital role in muscle regeneration and repair. However, disruptions in the satellite cell niche caused by severe trauma or surgery can hinder natural regeneration. Additionally, challenges such as limited availability of human donors and primary cells, difficulties in scaling satellite cell expansion, and storage issues present significant barriers. Therefore, developing engineered platforms that create optimized micro-niche environments to support muscle stem cells and promote muscle cell activity is crucial. Using non-direct 3D printing-guided phase separation technology and skeletal muscle extracellular matrix (ECM) hydrogel, we developed a digitally programmable, user-friendly, customizable, and biofunctional 3D platform that mimics the hierarchical porous structure and microenvironment of natural ECM. Notably, the synergistic combination of natural and synthetic matrices improves scalable satellite cell growth, supports autonomous myotube contraction, and accelerates in vivo myofiber and blood vessel formation, paving the way for increased production of myogenic precursors, cell therapies, and treatments for traumatic muscle injuries.